• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM S.R.L. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM S.R.L. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVF-L
Medical Device Problem Code Perivalvular Leak (1457)
Health Effect - Clinical Code Aortic Valve Insufficiency/ Regurgitation (4450)
Date of Event 05/22/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The manufacturing and material records for the device involved in this event, as they pertain to the reported issue, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this prosthesis satisfied all required material, visual, and performance standards at the time of manufacture and release.Since the device was disposed and was not available for return to the manufacturer, further investigaton on the device could not be performed.However, from the document review performed, no device deficiencies were noted.Since limited information is available, the definitive root cause of the reported event cannot be established at this time.It should be noted that due to the complexity of the procedure, it is reasonable to assume that the observed perivalvular leak could be related to positioning difficulties.Should further information be received in the future, a follow up report will be submitted.
 
Event or Problem Description
The manufacturer was informed of an intraoperative explant involving a perceval plus sutureless aortic heart valve, size l (pvf-l), which occurred on (b)(6) 2025.Reports indicate that a wheat procedure was carried out via a full sternotomy, involving the replacement of both the aortic valve and a portion of the ascending aorta.Following implantation, a paravalvular leak was detected, leading to the removal of the pvf-l valve and its replacement with a sutured inspiris valve size 23.Consequently, the duration of the surgery was extended by approximately 35-40 minutes.According to the information received, the valve's collapsing and implantation proceeded without issues.The explanted prosthesis was disposed of at the site, making it unavailable for return to the manufacturer for further assessment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE
Common Device Name
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM S.R.L.
via per crescentino sn
saluggia, vc 13040
IT  13040
Manufacturer (Section G)
CORCYM S.R.L.
via per crescentino sn
saluggia, vc 13040
IT   13040
Manufacturer Contact
laura mannino
5005 north fraser way
burnaby, bc V5J 5-M1
CA   V5J 5M1
MDR Report Key22294348
Report Number3005687633-2025-00118
Device Sequence Number8310386
Product Code LWR
UDI-Device Identifier08022057015389
UDI-Public(01)08022057015389(240)PVF-L(17)290314
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
P150011S013
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Device Explanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 06/19/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberPVF-L
Device Catalogue NumberPVF-L
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/23/2025
Initial Report FDA Received Date06/19/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/15/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-